Medical Manager Germany

Outlook Therapeutics, Inc.

Deutschland

Hybride

EUR 120 000 - 180 000

Plein temps

Il y a 6 jours
Soyez parmi les premiers à postuler

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Equity options
Annual bonus
Leadership access
Mission-driven work

Résumé du poste

Outlook Therapeutics, Inc. is seeking a Germany-based Medical Lead to shape and execute the country medical strategy for wet AMD.

You will be the scientific voice for German retina specialists, payers, and authorities, partnering with senior leadership to align medical workstreams with market access and regulatory programs. You will build relationships with national thought leaders, lead scientific exchanges at congresses and advisory boards, and deliver medical education in German and English

Qualifications

  • Advanced degree required (MD/PhD/PharmD or equivalent).
  • Fluent German and professional English.
  • Ophthalmology or retina experience or biologics in hospital setting.
  • Proven medical affairs or field medical experience in Germany.
  • Knowledge of German healthcare pricing and AMNOG/G-BA basics.
  • Ability to work autonomously with strategic impact.
  • Willingness to travel extensively in Germany and Europe.

Responsabilités

  • Own the Germany medical strategy and execution.
  • Translate EU strategy into German-market priorities.
  • Engage in compliant scientific exchange about wet AMD and LYTENAVA.
  • Develop and track KOL engagement plans.
  • Collaborate with Market Access, Regulatory, and Commercial teams.
  • Lead scientific exchanges at congresses and advisory boards.
  • Ensure activities comply with German laws and codes.
  • Travel extensively within Germany and periodically Europe.

Connaissances

Fluent German
Professional English
Medical affairs experience
Ophthalmology/retina exposure

Formation

MD/PhD/PharmD or equivalent

Description du poste

Committed to the preservation of vision.
Help bring the first ophthalmic formulation of bevacizumab to people living with wet AMD.

Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. Our lead product is the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission, the US FDA, and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and is now launching across Germany, Austria, the UK, and the United States. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.

THE OPPORTUNITY

Reports To - Medical Lead, Europe Dotted Line to General Manager, Europe
Location - Germany - Hybrid (home-based with regular travel across Germany and to European team onsites)
Employment Type - Full-time
Direct Reports - No

This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you'll help build the function rather than simply maintain it. You'll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.

You will contribute to the medical strategy for Germany and ensure excellence in execution of the strategy. You will become the trusted scientific voice for German retina specialists, payers, and authorities.

WHAT YOU’LL DO

Own the Germany medical strategy

  • Function as the primary medical point of contact in Germany.
  • Translate the European medical strategy into German-market priorities - scientific narrative, evidence gaps, data-generation opportunities, and congress presence.
  • Engage in well informed, compliant, robust, and accurate scientific exchange around the treatment of wet AMD, and the science surrounding LYTENAVA™ (bevacizumab gamma).
  • Develop and track Strategic KOL engagement plans - identify, develop, and maintain long-term collaborative relationships with KOLs within assigned region.
  • Engage in medical & scientific exchange with the medical/scientific community including advisory boards, congresses, and HCP offices.
  • Build relationships and assist in the development of key opinion leaders.
  • Build relationships with key decision makers in health systems, medical groups, healthcare provider offices, advocacy organizations, and national/regional professional societies.
  • Identify, attend and report on local/regional educational events such as national symposia and scientific/clinical meetings and CME events.
  • Provide insight into market trends and clinical intelligence.
  • Provide the medical input into AMNOG benefit-assessment work, G-BA and payer interactions, and medical review of promotional and non-promotional materials in partnership with Market Access, Regulatory, and Commercial.

Be the scientific face of the company in Germany

  • Build and personally maintain relationships with national retina thought leaders, academic centers, professional societies, and patient organizations.
  • Lead scientific exchange at national and regional congresses, advisory boards, and investigator meetings; deliver medical education to internal and external audiences in German and English.
  • Serve as the country's point of contact for medical information escalations and investigator-initiated study proposals, ensuring every interaction is compliant and documented.

Operate as a cross-functional partner

  • Partner daily with the Germany commercial, market access, and regulatory leads to hit country-level milestones; own the medical workstreams in Germany.
  • Ensure all medical activities comply with German law, the FSA/AKG codes, EFPIA, and company SOPs; be the person who knows where the lines are and keeps the team well inside them.
  • Report progress against the country medical plan with candor - wins, misses, and what changes next.
WHAT YOU’LL BRING

Required

  • Advanced scientific or medical degree (MD, PharmD, PhD, or equivalent); a medical degree is a plus but not required.
  • Fluent German and professional English, written and spoken.
  • Ophthalmology or retina therapeutic-area experience, or experience with biologics in a specialist hospital setting.
  • Demonstrated experience in medical affairs, field medical, or clinical roles in the pharmaceutical or biotech industry in Germany, with a track record of measurable results - we care more about what you have delivered than how many years it took.
  • Working knowledge of the German healthcare and pricing environment (AMNOG/G-BA, KV/GKV landscape) and the codes governing medical-HCP interaction.
  • Proven ability to operate autonomously with minimal direction: you set your own priorities, make decisions with incomplete information, and own the outcome.
  • Exceptional work ethic and drive - you are energized by ambitious targets and a small team where everything you do is visible.
  • Willingness to travel extensively within Germany and periodically across Europe.

Preferred

  • Launch experience in a specialty or hospital product, ideally as part of a small or first-in-country team.
  • Experience contributing to AMNOG dossiers, advisory boards, or investigator-initiated study programs
WHAT WE OFFER
  • Competitive base salary, annual performance bonus, and equity - so you share in the value you help create
  • A high-trust, low-bureaucracy culture with direct access to leadership and real room to grow
  • Mission-driven work that helps preserve sight for patients who are counting on it
OUR COMMITMENT

Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Medical Manager Germany
Medical Manager Germany

Outlook Therapeutics, Inc. • Bayern

Hybride
EUR 150 000 - 230 000
Competitive compensation
Annual bonus & equity
Growth opportunities
Medical Manager Ophthalmology
Medical Manager Ophthalmology

SUN PHARMA • Nordrhein-Westfalen

Sur place
EUR 70 000 - 100 000
Brand Lead - Germany
Brand Lead - Germany

Apellis Pharmaceuticals • München

Sur place
EUR 90 000 - 110 000
Comprehensive benefits package
Flexible time off
Paid family leave
Associate Director Regional Market Access Territory: Baden-Württemberg/Rheinland-Pfalz/Saarland
Associate Director Regional Market Access Territory: Baden-Württemberg/Rheinland-Pfalz/Saarland

Alexion Pharmaceuticals, Inc. • München

Hybride
EUR 70 000 - 110 000
Associate Director Regional Market Access Territory: Baden-Württemberg/Rheinland-Pfalz/Saarland
Associate Director Regional Market Access Territory: Baden-Württemberg/Rheinland-Pfalz/Saarland

AstraZeneca plc • München

Sur place
EUR 90 000 - 120 000
Medical Science Liaison, Solid Tumors – South Germany
Medical Science Liaison, Solid Tumors – South Germany

BeOne Medicines • Allemagne

Sur place
USD 125 618 - 157 052
Senior Medical Science Liaison, Solid Tumors - South Germany
Senior Medical Science Liaison, Solid Tumors - South Germany

BeiGene, Ltd. • Allemagne

À distance
EUR 109 000 - 136 000
Associate Director, Medical Operations, Germany
Associate Director, Medical Operations, Germany

Revolution Medicines, Inc. • München

Sur place
EUR 130 000 - 170 000
Director, Medical Affairs
Director, Medical Affairs

2010 Gilead Sciences GmbH • München

Sur place
EUR 150 000 - 190 000
Director Market Access - Innovative products (m/f/d)
Director Market Access - Innovative products (m/f/d)

Viatris • Bad Homburg vor der Höhe

Sur place
EUR 120 000 - 165 000
Excellent career progression
Work-life balance initiatives
Attractive bonus & pension
+1